Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLG)

Last Price

0.68

Today's Change

+0.01 (1.49%)

Day's Change

0.66 - 0.69

Trading Volume

7,888

Overview

Market Cap

2 Million

Shares Outstanding

3 Million

Avg Volume

167,848

Avg Price (50 Days)

0.87

Avg Price (200 Days)

1.28

PE Ratio

-0.14

EPS

-4.83

Earnings Announcement

12-May-2025

Previous Close

0.67

Open

0.70

Day's Range

0.6603 - 0.6963

Year Range

0.64 - 4.25

Trading Volume

30,123

Price Change Highlight

1 Day Change

1.45%

5 Day Change

-5.24%

1 Month Change

-17.27%

3 Month Change

-32.67%

6 Month Change

-66.34%

Ytd Change

-30.75%

1 Year Change

-57.50%

3 Year Change

-99.76%

5 Year Change

-99.95%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment